Merck: Said on Tuesday that it has entered

Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 million to develop an experimental cancer therapy. Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck , its subsidiaries or affiliates, except as noted. Merck & Co. is a global leader in developing and producing medicines, vaccines, biologic therapies and animal health products. It has several blockbuster products, such as Keytruda, Januvia, Gardasil and Varivax, and operates as Merck Sharp & Dohme or MSD outside the US and Canada. Merck offers chemicals for applications in laboratories and industry. Biosciences, biopharma, food, cosmetics, LCDs, pharmaceuticals, printing, plastics and coating